Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity

BACKGROUND: Recombinant allergens are under investigation for replacing allergen extracts in immunotherapy. Site-directed mutagenesis has been suggested as a strategy to develop hypoallergenic molecules that will reduce the risk of side effects. For decades, chemically modified allergen extracts hav...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Versteeg, Serge A., Bulder, Ingrid, Himly, Martin, van Capel, Toni M., van den Hout, R., Koppelman, Stef J., de Jong, Esther C., Ferreira, Fatima, van Ree, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: World Allergy Organization Journal 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488918/
https://ncbi.nlm.nih.gov/pubmed/23268458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WOX.0b013e3182228a39
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados